Anti-QPRT antibody [EPR11941(B)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal QPRT antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 8 publications.
View Alternative Names
Nicotinate-nucleotide pyrophosphorylase [carboxylating], Quinolinate phosphoribosyltransferase [decarboxylating], QAPRTase, QPRTase, QPRT
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-QPRT antibody [EPR11941(B)] (AB171944)
Intracellular flow cytometric analysis of permeabilized Jurkat cells labeling QPRTwith ab171944 at 1/10 (red)or a rabbit IgG (negative) (green).
- IP
Lab
Immunoprecipitation - Anti-QPRT antibody [EPR11941(B)] (AB171944)
Immunoprecipitation of QPRT in HAP1 cells. Lysates were prepared and immunoprecipitation was performed using 2.0 µg of ab171944 pre-coupled to Protein A beads. Samples were washed and processed for western blot with ab171944 at 1/1000
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
Lane 1:
Immunoprecipitation - Anti-QPRT antibody [EPR11941(B)] (ab171944) at 1/1000 dilution
Lane 3:
Immunoprecipitation - Anti-QPRT antibody [EPR11941(B)] (ab171944) at 2 µg
All lanes:
HAP1 cells
Observed band size: 31 kDa
false
- WB
Lab
Western blot - Anti-QPRT antibody [EPR11941(B)] (AB171944)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : QPRT knockout HAP1 cell lysate (20 μg)
Lane 3 : HepG2 cell lysate (20 μg)
Lane 4 : Human fetal brain cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab171944 observed at 35 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab171944 was shown to specifically react with QPRT when QPRT knockout samples were used. Wild-type and QPRT knockout samples were subjected to SDS-PAGE. ab171944 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-QPRT antibody [EPR11941(B)] (ab171944)
Predicted band size: 31 kDa
false
- WB
Supplier Data
Western blot - Anti-QPRT antibody [EPR11941(B)] (AB171944)
All lanes:
Western blot - Anti-QPRT antibody [EPR11941(B)] (ab171944) at 1/1000 dilution
Lane 1:
Human fetal kidney tissue lysate at 10 µg
Lane 2:
Human fetal liver tissue lysate at 10 µg
Lane 3:
HepG2 cell lysate at 10 µg
Lane 4:
HeLa cell lysate at 10 µg
Lane 5:
Jurkat cell lysate at 10 µg
Lane 6:
Human fetal heart tissue lysate at 10 µg
Predicted band size: 31 kDa
true
- WB
Lab
Western blot - Anti-QPRT antibody [EPR11941(B)] (AB171944)
ab171944 was shown to react with QPRT in wild-type HAP1 cells in Western blot with loss of signal observed in a QPRT knockout cell line. Wild-type HAP1 and QPRT knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab171944 overnight at 4 °C at a 1/500 dilution. Blots were incubated with secondary antibodies at 0.2ug/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-QPRT antibody [EPR11941(B)] (ab171944) at 1/500 dilution
Lane 1:
Wild-type HAP1 lysate at 20 µg
Lane 2:
QPRT knock-out HAP1 lysate at 20 µg
Predicted band size: 31 kDa
false
Related conjugates and formulations (1)
-
Anti-QPRT antibody [EPR11941(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
QPRT influences the synthesis of NAD+ which is essential for cellular redox reactions and energy metabolism. The enzyme operates as a monomer and does not typically form part of a larger complex. However its activity is important in maintaining NAD+ levels which can impact a wide range of cellular processes such as DNA repair signal transduction and metabolism.
Pathways
QPRT holds a significant role in the kynurenine pathway and NAD+ biosynthesis. This pathway includes several enzymes such as kynurenine 3-monooxygenase and kynureninase which collaboratively contribute to the degradation of tryptophan ultimately affecting the levels of important coenzymes and neurotransmitters. The NAD+ biosynthesis pathway involving QPRT also interacts with pathways for ATP generation connecting with other metabolic processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
iScience 27:109358 PubMed38544565
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:8095 PubMed38092728
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 14: PubMed35626147
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:633035 PubMed34540820
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 12:575830 PubMed34079576
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 12:14754-14774 PubMed32716908
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 20:1467-1479 PubMed32742380
2020
Applications
Unspecified application
Species
Unspecified reactive species
FEBS letters 594:1379-1388 PubMed31950503
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com